LICENSE AGREEMENTLicense Agreement • May 3rd, 2010 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledMay 3rd, 2010 Company Industry JurisdictionThis AGREEMENT (“Agreement”), dated December 3, 2008 is made by and between BioSante Pharmaceuticals, Inc., 111 Barclay Boulevard, Lincolnshire, IL 60069 (“BPA”), and Azur Pharma International II Limited, a Bermuda limited liability company, Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda and such of its Affiliates as it may designate from time to time under one or more provisions of this Agreement (“Company”).
AMENDMENT NO. 1 TO LICENSE AGREEMENT AND ASSET PURCHASE AGREEMENTLicense Agreement and Asset Purchase Agreement • May 3rd, 2010 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Contract Type FiledMay 3rd, 2010 Company IndustryThis AGREEMENT (“Amendment”), dated November 30, 2009 (the “Amendment Effective Date”) is made by and between BioSante Pharmaceuticals, Inc., 111 Barclay Boulevard, Lincolnshire, IL 60069 (“BPA”), and Azur Pharma International II Limited, a Bermuda limited liability company, Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda and such of its Affiliates as it may designate from time to time under one or more provisions of this Agreement (“Company”).